Table 1 Relationship between clinicopathological features and CBFA2T2 expression
From: CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma
Variables | CBFA2T2 expression | p value | |
|---|---|---|---|
Low (n = 31) | High (35) | ||
Gender | |||
Male | 22 (71.4%) | 25 (70.3%) | 0.214 |
Female | 9 (28.6%) | 10 (29.7%) | |
Fuhrman grade | |||
G1–2 | 14 (66.7%) | 23 (65.7%) | 0.023 |
G3–4 | 9 (33.3%) | 3 (8.6%) | |
Unknown | 8 (23.5%) | 9 (25.7%) | |
pT stage | |||
pT1–2 | 16 (51.6%) | 24 (68.6%) | 0.104 |
pT3–4 | 8 (25.8%) | 5 (14.3%) | |
Unknown | 7 (22.6%) | 6 (17.1%) | |
Lymph node metastasis | |||
Absence | 26 (83.9%) | 27 (77.1%) | 0.382 |
Presence | 2 (6.5%) | 1 (2.9%) | |
Unknown | 3 (9.7%) | 7 (20%) | |
Systematic metastasis | |||
Absence | 27 (87.1%) | 27 (77.1%) | 0.293 |
Presence | 3 (9.7%) | 4 (11.4%) | |
Unknown | 1 (3.2%) | 4 (11.4%) | |
Pathological type | |||
ccRCC | 25 (80.6%) | 25 (71.4%) | 0.158 |
non-ccRCC | 6 (19.4%) | 10 (28.6%) | |